Faculty Opinions recommendation of Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial.

Author(s):  
Adam Skolnick
The Lancet ◽  
2019 ◽  
Vol 393 (10188) ◽  
pp. 2312-2321 ◽  
Author(s):  
Philipp Schuetz ◽  
Rebecca Fehr ◽  
Valerie Baechli ◽  
Martina Geiser ◽  
Manuela Deiss ◽  
...  

1992 ◽  
Vol 11 (4) ◽  
pp. 180-186 ◽  
Author(s):  
M.F. Von Meyenfeldt ◽  
W.J.H.J. Meijerink ◽  
M.M.J. Rouflart ◽  
M.T.H.J. Builmaassen ◽  
P.B. Soeters

2019 ◽  
Vol 2 (11) ◽  
pp. e1915138 ◽  
Author(s):  
Filomena Gomes ◽  
Annic Baumgartner ◽  
Lisa Bounoure ◽  
Martina Bally ◽  
Nicolaas E. Deutz ◽  
...  

2019 ◽  
Vol 8 (8) ◽  
pp. 1130 ◽  
Author(s):  
Emilie Reber ◽  
Filomena Gomes ◽  
Lia Bally ◽  
Philipp Schuetz ◽  
Zeno Stanga

Malnutrition is a common condition in hospitalized patients that is often underdiagnosed and undertreated. Hospital malnutrition has multifactorial causes and is associated with negative clinical and economic outcomes. There is now growing evidence from clinical trials for the efficiency and efficacy of nutritional support in the medical inpatient population. Since many medical inpatients at nutritional risk or malnourished are polymorbid (i.e., suffer from multiple comorbidities), this makes the provision of adequate nutritional support a challenging task, given that most of the clinical nutrition guidelines are dedicated to single diseases. This review summarizes the current level of evidence for nutritional support in not critically ill polymorbid medical inpatients.


2020 ◽  
Vol 12 ◽  
pp. 175883591989028
Author(s):  
Riccardo Caccialanza ◽  
Emanuele Cereda ◽  
Catherine Klersy ◽  
Silvia Brugnatelli ◽  
Valeria Borioli ◽  
...  

Background: Malnutrition is common in cancer patients, particularly in those affected by gastrointestinal malignancies, and negatively affects treatment tolerance, survival, functional status, and quality of life (QoL). Nutritional support, including supplemental parenteral nutrition (SPN), has been recommended at the earliest opportunity in malnourished cancer patients. The limited available evidence on the efficacy of SPN in gastrointestinal cancer patients is positive, particularly with regards to QoL, body composition, and energy intake, but the evidence on survival is still scanty. Furthermore, studies regarding the early administration of SPN in combination with nutritional counseling from the beginning of first-line chemotherapy (CT) are lacking. We hypothesize that early systematic SPN in combination with nutritional counseling (NC), compared with NC alone, can benefit patients with previously untreated metastatic gastric cancer at nutritional risk undergoing first-line CT. Methods: The aim of this pragmatic, multicenter, randomized (1:1), parallel-group, open-label, controlled clinical trial is to evaluate the efficacy in terms of survival, weight maintenance, body composition, QoL and feasibility of cancer therapy of early systematic SNP. This is in combination with NC, compared with NC alone, in treatment-naïve metastatic gastric cancer patients at nutritional risk undergoing first-line CT. Discussion: Malnutrition in oncology remains an overlooked problem. Although the importance of SPN in gastrointestinal cancer patients has been acknowledged, no studies have yet evaluated the efficacy of early SPN in metastatic gastric patients undergoing CT. The present study, which guarantees the early provision of nutritional assessment and support to all the enrolled patients in accordance with the recent guidelines and recommendations, could represent one of the first proofs of the clinical effectiveness of early intensive nutritional support in cancer patients undergoing CT. This study could stimulate further large randomized trials in different cancer types, potentially resulting in the improvement of supportive care quality. Trial registration: This study is registered on ClinicalTrials.gov: NCT03949907.


Sign in / Sign up

Export Citation Format

Share Document